Why Black Myeloma Patients and Their Families Should Care about the PROMISE Study image

Why Black Myeloma Patients and Their Families Should Care about the PROMISE Study

Oct 27, 2022
02:00PM - 03:00PM EDT
Online Event
Overview

Join Dr. Monique Hartley-Brown, a Black myeloma specialist as she shares why the Black community should care about the myeloma PROMISE study. It’s the first study to test those who identify as Black or African American who may be at risk for the multiple myeloma precursor condition Monoclonal Gammopathy of Undetermined Significance (MGUS). The study aims to make multiple myeloma a preventable cancer.

Let's spread the word about this easy-to-manage at-home study so we can better understand what is driving myeloma growth and what the Black Myeloma Community can do to prevent it.

Agenda
02:00 PM
Introduction
Valarie Traynham
Valarie introduces the agenda of the event and featured speaker Dr. Monique Hartley-Brown.
02:05 PM
Presentation
Monique Hartley-Brown, MD
Dr. Monique Hartley-Brown shares why the Black community should care about the myeloma PROMISE study.
02:35 PM
Questions and Answers
Audience
Type your questions in the chat and we will answer them!
Speakers & Moderators
Healthtree contact Valarie Traynham

Valarie Traynham

Valarie embarked on her myeloma journey back in 2015, and ever since she's been on a mission. As a resilient myeloma thriver, her passion lies in not just navigating her own path but also in illuminating the journey for others. With a steadfast commitment to understanding the intricacies of the disease, she champions education, shedding light on health inequities that often lurk in the shadows. Driven by a profound belief in fairness, Valarie tirelessly advocates for equitable access to top-tier healthcare, clinical trials, and tailored treatments. Her journey as a beacon of knowledge and support began when she assumed the role of a support group leader. Today, she continues to extend her hand as a myeloma coach, mentor angel, and the guiding force behind the Black Myeloma Health Community. Valarie's voice echoes far and wide as she fearlessly confronts the disparities faced by myeloma patients. Through collaborative efforts with healthcare providers, she strives to forge pathways to solutions, ensuring that every individual receives the care they deserve. Join Valarie on her journey of empowerment and advocacy as she lights the way toward a brighter, more equitable future in myeloma care.
Healthtree contact Monique Hartley-Brown, MD

Monique Hartley-Brown, MD

Dr. Hartley-Brown is an emerging leader in the field of Multiple Myeloma. She is an Associate Physician at Harvard Medical School and Assistant Professor & Medical Oncologist who specializes in treating patients with multiple myeloma. She practices clinical care at the Jerome Lipper Multiple Myeloma Center at Dana-Farber Cancer Institute. Multiple myeloma is an incurable cancer that affects Black Americans approximately twice more than Caucasians. Dr. Hartley-Brown has written several publications and has been a clinical research investigator for numerous clinical studies that has contributed to the advancement of clinical care for patients with multiple myeloma and plasma cell dyscrasias. As a Black female physician, she is dedicated to ensuring that the care for the myeloma community is equitable and affords all patients with myeloma an optimal level of care regardless of background, race or socioeconomic status.